News for DaVita Inc. (DVA.MX)

DaVita Inc. (DVA) recently held its virtual 2025 Annual Meeting of Stockholders on June 5, 2025. The meeting saw participation from shareholders representing

Summary DaVita Inc (DVA), a leading comprehensive kidney care company, has expressed its support for the Center for Medicare and Medicaid Innovation's (CMMI) de

Summary: DaVita Inc. (DVA) boosts its senior notes offering to $1 billion with plans to use proceeds for debt repayment. Analyst forecasts suggest a 13.1

Truist has revised its price target for DaVita (DVA), lowering it from $170 to $164, while maintaining a Hold rating on the shares. This adjustment follows an a

On May 19, 2025, analyst David Macdonald from Truist Securities released a report on DaVita (DVA), maintaining a "Hold" rating but lowering the price target fro

TD Cowen's analyst, Gary Taylor, has adjusted the target price for DaVita (DVA), decreasing it from $165 to $157 while maintaining a Hold rating on the stock. T

The move occurred just a day before a union health benefits fund sued top dialysis services providers in the country, including DaVita Inc.

According to a Form 4 filing with the United States Securities and Exchange Commission, on May 8, Berkshire Hathaway sold 1,145,938 shares of DaVita Inc. (NYSE:DVA), valued at $168.58 million. The move occurred just a day before a union health benefits fund sued top dialysis services providers in the country, including DaVita Inc. (NYSE:DVA), for […]

As legendary investor Warren Buffett prepares to step down as CEO of Berkshire Hathaway Inc. (NYSE:BRK) (NYSE:BRK) by the end of 2025, a 13F filing released on Thursday reveals how his team reshaped the firm's portfolio in the first quarter. What ...

Exploring the Investment Strategies of a Renowned Value Investor John Rogers (Trades, Portfolio) recently submitted the 13F filing for the first quarter of 202

We recently published a list of 15 Small-Cap Healthcare Stocks Hedge Funds Are Buying. In this article, we are going to take a look at where DaVita Inc. (NYSE:DVA) stands against other small-cap healthcare stocks hedge funds are buying. The U.S. healthcare sector has performed better in 2025 compared to the broader market. After two […]

Adjusted Operating Income: $439 million for Q1 2025.Adjusted Earnings Per Share (EPS): $2 for Q1 2025.Free Cash Flow: Negative $45 million for Q1 2025.US Treat

PR NewswireDENVER, May 12, 2025 DENVER, May 12, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ende

DaVita Inc. (DVA) recently announced its financial earnings for the first quarter, reporting a revenue of $3.2 billion, slightly below the market's expectation

Revenue: Achieved $3.224 billion, surpassing the estimated $3.206 billion.Earnings Per Share (EPS): Reported at $2.00, exceeding the estimated EPS of $1.97.Ope

DaVita (DVA) has maintained its forecast for free cash flow ranging between $1.0 billion and $1.25 billion for the year 2025. The company remains confident in i

Market Analysis by covering: S&P 500, Walt Disney Company, Clorox Co, Walmart Inc. Read 's Market Analysis on Investing.com

U.S. stock futures jumped on Monday after a muted day of trade on Friday. Futures of benchmark indices were trading over 2% in premarket.

The CNN Money Fear and Greed index showed almost no change in the overall market sentiment, while the index remained in the “Greed” zone on Friday. U.S. st...